EXCLI Journal最新文献

筛选
英文 中文
Reply to the letter to the editor by Manzoli, Acuti Martelucci and Flacco (doi: 10.17179/excli2025-9176). 回复Manzoli, Acuti Martelucci和Flacco给编辑的信(doi: 10.17179/excli2025-9176)。
IF 4.9 3区 生物学
EXCLI Journal Pub Date : 2026-04-15 eCollection Date: 2026-01-01 DOI: 10.17179/excli2026-9442
Marco Alessandria, Franco Berrino, Giovanni M Malatesta, Alberto Donzelli
{"title":"Reply to the letter to the editor by Manzoli, Acuti Martelucci and Flacco (doi: 10.17179/excli2025-9176).","authors":"Marco Alessandria, Franco Berrino, Giovanni M Malatesta, Alberto Donzelli","doi":"10.17179/excli2026-9442","DOIUrl":"https://doi.org/10.17179/excli2026-9442","url":null,"abstract":"","PeriodicalId":12247,"journal":{"name":"EXCLI Journal","volume":"25 ","pages":"476-478"},"PeriodicalIF":4.9,"publicationDate":"2026-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13139733/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147835632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Second reply to the second letter to the editor by Alessandria, Berrino, Malatesta and Donzelli (doi: 10.17179/excli2026-9442). Alessandria, Berrino, Malatesta和Donzelli给编辑的第二封回信(doi: 10.17179/excli2026-9442)。
IF 4.9 3区 生物学
EXCLI Journal Pub Date : 2026-04-15 eCollection Date: 2026-01-01 DOI: 10.17179/excli2026-9443
Lamberto Manzoli, Cecilia Acuti Martellucci, Maria Elena Flacco
{"title":"Second reply to the second letter to the editor by Alessandria, Berrino, Malatesta and Donzelli (doi: 10.17179/excli2026-9442).","authors":"Lamberto Manzoli, Cecilia Acuti Martellucci, Maria Elena Flacco","doi":"10.17179/excli2026-9443","DOIUrl":"https://doi.org/10.17179/excli2026-9443","url":null,"abstract":"","PeriodicalId":12247,"journal":{"name":"EXCLI Journal","volume":"25 ","pages":"479-480"},"PeriodicalIF":4.9,"publicationDate":"2026-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13139735/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147835600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic diagnosis and molecular characterization of three novel variations in the phenylalanine hydroxylase gene from Chinese patients with phenylketonuria. 中国苯丙酮尿患者苯丙氨酸羟化酶基因三种新变异的遗传诊断和分子特征。
IF 4.9 3区 生物学
EXCLI Journal Pub Date : 2026-04-10 eCollection Date: 2026-01-01 DOI: 10.17179/excli2026-9271
Fan Yang, Hua-Feng Li, Wei-Jia Tang, Jin-Ping Zhu, Ji-Gang Qiu, Tian-E Cai, Li-Mei Yu, Ying Yu
{"title":"Genetic diagnosis and molecular characterization of three novel variations in the phenylalanine hydroxylase gene from Chinese patients with phenylketonuria.","authors":"Fan Yang, Hua-Feng Li, Wei-Jia Tang, Jin-Ping Zhu, Ji-Gang Qiu, Tian-E Cai, Li-Mei Yu, Ying Yu","doi":"10.17179/excli2026-9271","DOIUrl":"https://doi.org/10.17179/excli2026-9271","url":null,"abstract":"<p><p>Loss-of-function variants in the human <i>phenylalanine hydroxylase</i> (<i>PAH</i>) gene are the most common genetic causal factors for Phenylketonuria (PKU). Currently, a broad spectrum of variations is recognized in the human <i>PAH</i> gene. However, the molecular function and clinical significance of some novel <i>PAH</i> variants remain unclear. Here, we report on five PKU-affected families carrying three novel <i>PAH</i> variants, including one missense variant (<i>PAH</i>: c.271C>A (p.Leu91Met)) and two deletions (<i>PAH</i>: c.206_208delCTT (p.Ser70del) and <i>PAH</i>: c.541_544delGAGG (p.Glu181Lysfs*13)). These variations constitute different compound heterozygous genotypes with other known pathogenic variants such as <i>PAH</i>: c.721C>T (p.Arg241Cys), <i>PAH</i>: c.168+5G>C, and <i>PAH</i>: c.1238G>C (p.Arg413Pro), which probably led to the patients' PKU etiopathology. qRT-PCR and immunoblotting showed that the protein levels of PAH (S70del) and PAH (E181Kfs*13) were significantly reduced compared with the wild-type control, although their transcript levels were not. Also, the enzyme activity of PAH (S70del) and PAH (E181Kfs*13) mutants was significantly decreased relative to the wild type (<i>P</i> < 0.001). <i>PAH</i>: c.271C>A (p.Leu91Met) had no significant effect on <i>PAH</i> mRNA and protein levels or enzyme activity. Collectively, our data demonstrate that the two deletions <i>PAH</i>: c.206_208delCTT and <i>PAH</i>: c.541_544delGAGG are clinically significant for pathogenicity. Our findings are anticipated to contribute to the advancement of prenatal diagnosis, population-based carrier screening, and genetic counseling for individuals affected by PKU, and is expected to help reduce the incidence of PKU and ameliorate the associated disease burden. See also the graphical abstract(Fig. 1).</p>","PeriodicalId":12247,"journal":{"name":"EXCLI Journal","volume":"25 ","pages":"458-475"},"PeriodicalIF":4.9,"publicationDate":"2026-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13139738/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147835642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circadian clock regulation in lung health and disease: molecular mechanisms and therapeutic opportunities. 肺健康和疾病中的生物钟调节:分子机制和治疗机会。
IF 4.9 3区 生物学
EXCLI Journal Pub Date : 2026-04-08 eCollection Date: 2026-01-01 DOI: 10.17179/excli2026-9372
Prabesh Baniya, Swekriti Puri, Nisha Panth, Rajan Thapa, Madhu Gupta, Sachin Kumar Singh, Rohit Bhatia, Gaurav Gupta, Kamal Dua, Keshav Raj Paudel
{"title":"Circadian clock regulation in lung health and disease: molecular mechanisms and therapeutic opportunities.","authors":"Prabesh Baniya, Swekriti Puri, Nisha Panth, Rajan Thapa, Madhu Gupta, Sachin Kumar Singh, Rohit Bhatia, Gaurav Gupta, Kamal Dua, Keshav Raj Paudel","doi":"10.17179/excli2026-9372","DOIUrl":"https://doi.org/10.17179/excli2026-9372","url":null,"abstract":"<p><p>Circadian rhythms are endogenous time-keeping mechanisms that organize physiological and cellular functions into approximately 24-hour cycles. These rhythms are generated by conserved molecular clocks composed of interconnected transcription-translation feedback loops involving core regulators such as CLOCK, BMAL1, PERIOD, CRYPTOCHROME, REV-ERB, and ROR proteins. While circadian regulation is best known for governing sleep-wake behavior, mounting evidence demonstrates that peripheral clocks exert critical control over organ-specific physiology. The lung represents a highly rhythmic tissue in which local circadian oscillators coordinate airway tone, immune surveillance, inflammatory signaling, epithelial repair, and metabolic homeostasis. Disruption of circadian timing arising from genetic alterations, environmental stressors, shift work, irregular light exposure, or chronic inflammation has emerged as an important contributor to the development and progression of multiple respiratory diseases, including asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, acute lung injury, sleep-disordered breathing, and lung cancer. At the mechanistic level, dysregulation of clock genes alters inflammatory pathways, oxidative stress responses, mitochondrial metabolism, and cell-cycle control, thereby exacerbating tissue injury and impairing resolution and repair. Recognition of these temporal influences has prompted growing interest in circadian-based therapeutic strategies. Chronotherapy, which aligns drug administration with endogenous biological rhythms, and pharmacological targeting of clock components such as REV-ERBs and RORs, offer promising avenues to improve treatment efficacy while limiting adverse effects. This review integrates current insights into circadian clock architecture, lung-specific regulation, disease mechanisms, and therapeutic potential, highlighting circadian biology as a critical yet underutilized dimension of respiratory medicine. See also the graphical abstract(Fig. 1).</p>","PeriodicalId":12247,"journal":{"name":"EXCLI Journal","volume":"25 ","pages":"427-457"},"PeriodicalIF":4.9,"publicationDate":"2026-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13139736/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147835628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paracetamol in pregnancy: Navigating clinical uncertainty and avoiding the communication pitfalls of the "measles, mumps, and rubella" - autism controversy: A narrative review. 妊娠期扑热息痛:导航临床不确定性和避免沟通陷阱的“麻疹,腮腺炎和风疹”-自闭症争议:叙述回顾。
IF 4.9 3区 生物学
EXCLI Journal Pub Date : 2026-04-07 eCollection Date: 2026-01-01 DOI: 10.17179/excli2026-9237
Helmi Ben Saad, Chamseddine Barki, Ismail Dergaa, Wissem Dhahbi, Halil Ibrahim Ceylan, Nasr Chalghaf, Abdelfatteh El Omri, Hanene Boussi Rahmouni
{"title":"Paracetamol in pregnancy: Navigating clinical uncertainty and avoiding the communication pitfalls of the \"measles, mumps, and rubella\" - autism controversy: A narrative review.","authors":"Helmi Ben Saad, Chamseddine Barki, Ismail Dergaa, Wissem Dhahbi, Halil Ibrahim Ceylan, Nasr Chalghaf, Abdelfatteh El Omri, Hanene Boussi Rahmouni","doi":"10.17179/excli2026-9237","DOIUrl":"https://doi.org/10.17179/excli2026-9237","url":null,"abstract":"<p><p>On September 22, 2025, the United States government announced that the Food and Drug Administration (FDA) would modify paracetamol (acetaminophen) labelling to warn of possible associations with autism, advising pregnant individuals to avoid the medication. This contradicts professional medical consensus and high-quality evidence, replicating communication failures of the 1998 MMR-autism controversy that caused vaccine hesitancy, disease outbreaks, and trust erosion. This narrative review synthesized epidemiological evidence on paracetamol safety in pregnancy, analyzed the September 2025 announcement through the measles, mumps, and rubella (MMR)-autism crisis lens, and proposed an evidence-based communication framework. We searched <i>PubMed</i>, <i>Embase</i>, <i>Web of Science</i>, and <i>Google Scholar</i>, supplemented with governmental statements, professional responses, and media analysis. The two highest-quality sibling-control studies (Swedish: 2.5 million; Japanese: 200,000 children) reported no causal associations between prenatal paracetamol exposure and neurodevelopmental outcomes after controlling genetic and familial confounding. Conversely, untreated maternal fever and pain carry established risks including neural tube defects, preterm birth, and maternal morbidity. The governmental announcement employed inflammatory categorical warnings contradicting FDA's nuanced advisory and scientific consensus. Professional organizations immediately issued strong rebuttals. This replicates MMR failures: governmental statements contradicting evidence, false media balance, and public confusion. The September 2025 announcement represents failure to apply MMR lessons. Healthcare providers must employ evidence-based shared decision-making emphasizing sibling-controlled studies show no causal relationship while untreated conditions carry established harms. The Precautionary Communication Principle provides framework for transparent uncertainty discussion without disproportionate alarm or undermining evidence-based medicine trust. See also the graphical abstract(Fig. 1).</p>","PeriodicalId":12247,"journal":{"name":"EXCLI Journal","volume":"25 ","pages":"400-426"},"PeriodicalIF":4.9,"publicationDate":"2026-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13139739/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147835629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Marine algae as emerging therapeutics in lung health. 海藻作为肺部健康的新兴疗法。
IF 4.9 3区 生物学
EXCLI Journal Pub Date : 2026-04-02 eCollection Date: 2026-01-01 DOI: 10.17179/excli2026-9388
Prisca Deviani Pakan, Kiruthika Narayanan, Dennis Chang, Keshav Raj Paudel, Kamal Dua
{"title":"Marine algae as emerging therapeutics in lung health.","authors":"Prisca Deviani Pakan, Kiruthika Narayanan, Dennis Chang, Keshav Raj Paudel, Kamal Dua","doi":"10.17179/excli2026-9388","DOIUrl":"https://doi.org/10.17179/excli2026-9388","url":null,"abstract":"","PeriodicalId":12247,"journal":{"name":"EXCLI Journal","volume":"25 ","pages":"396-399"},"PeriodicalIF":4.9,"publicationDate":"2026-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13139734/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147835560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polymorphism engineering of mefenamic acid for enhanced pharmacokinetic performance. 甲氧胺酸多态工程提高药动学性能。
IF 4.9 3区 生物学
EXCLI Journal Pub Date : 2026-03-17 eCollection Date: 2026-01-01 DOI: 10.17179/excli2026-9258
Parteek Prasher, Mousmee Sharma
{"title":"Polymorphism engineering of mefenamic acid for enhanced pharmacokinetic performance.","authors":"Parteek Prasher, Mousmee Sharma","doi":"10.17179/excli2026-9258","DOIUrl":"https://doi.org/10.17179/excli2026-9258","url":null,"abstract":"<p><p>Mefenamic acid, a BCS Class II drug, continues to face the longstanding challenges related to its suboptimal solubility and variable absorption, which necessitates frequent dosing of the drug resulting in ulcerogenicity. Guided by its polymorphic forms, the co-crystallization of mefenamic acid offers a unique advantage over the other advanced formulation strategies, including hydrotropy, nanosizing, and complexation for improving the drug bioavailability. However, the contemporary research limited only to the proof-of-concept studies fails to provide a clinical evidence or translational insights, which necessitates the rational design of synthons and engineering of the solid-state landscape of the drug for developing the co-crystallization formulation of mefenamic acid. This commentary provides critical insights into the polymorphism-driven co-crystal design of mefenamic acid aimed at filling the critical gaps in scalability and clinical translation.</p>","PeriodicalId":12247,"journal":{"name":"EXCLI Journal","volume":"25 ","pages":"390-395"},"PeriodicalIF":4.9,"publicationDate":"2026-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13139737/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147835613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cornered professors, a fragilized model, and graduate training… who holds it together? 走投无路的教授、脆弱的模式和研究生培训……是谁维系着这一切?
IF 4.9 3区 生物学
EXCLI Journal Pub Date : 2026-03-11 eCollection Date: 2026-01-01 DOI: 10.17179/excli2026-9340
Mairim R Serafini, Lucindo J Quintans-Júnior
{"title":"Cornered professors, a fragilized model, and graduate training… who holds it together?","authors":"Mairim R Serafini, Lucindo J Quintans-Júnior","doi":"10.17179/excli2026-9340","DOIUrl":"https://doi.org/10.17179/excli2026-9340","url":null,"abstract":"","PeriodicalId":12247,"journal":{"name":"EXCLI Journal","volume":"25 ","pages":"387-389"},"PeriodicalIF":4.9,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13077161/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147689062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MAGEB16 as an epigenetic timing regulator linking X-chromosome biology to neurodevelopmental vulnerability in Autism Spectrum Disorder. MAGEB16:自闭症谱系障碍患者x染色体生物学与神经发育易感性之间的表观遗传调控因子
IF 4.9 3区 生物学
EXCLI Journal Pub Date : 2026-03-06 eCollection Date: 2026-01-01 DOI: 10.17179/excli2026-9338
John Antonydas Gaspar, Krishnan M Dhandapani, David C Hess
{"title":"MAGEB16 as an epigenetic timing regulator linking X-chromosome biology to neurodevelopmental vulnerability in Autism Spectrum Disorder.","authors":"John Antonydas Gaspar, Krishnan M Dhandapani, David C Hess","doi":"10.17179/excli2026-9338","DOIUrl":"https://doi.org/10.17179/excli2026-9338","url":null,"abstract":"<p><p>MAGEB16 (Melanoma-associated antigen B16) is an X-linked cancer-testis antigen belonging to the MAGE-B family, whose expression is tightly regulated by a promoter DNA-methylation switch that restricts transcription primarily to the male germ line under normal physiological conditions. In addition to its established roles in spermatogenesis and oncogenesis, emerging functional, epigenomic, and genetic evidence points to MAGEB16 as an epigenetically sensitive modifier of early developmental programs implicated in neurodevelopmental disorders such as Autism Spectrum Disorder (ASD). In this study, we performed an integrative analysis combining MAGEB16's chromosomal context, molecular interaction networks, and methylation-dependent regulatory features, alongside experimental depletion datasets from pluripotent stem cells, perinatal cord-blood methylome data from ASD cohorts, peripheral transcriptomics linked to neuropsychiatric risk and recently reported genetic variant associations. Our synthesis identifies underlying evidence indicating that MAGEB16 participates in epigenetically regulated lineage specification processes during early embryonic development. We propose a unified model in which MAGEB16 acts as a dosage- and timing-dependent regulator of early lineage commitment. Disruption of its epigenetic control, particularly during X-chromosome-enriched developmental periods, may influence neurodevelopmental pathways toward ASD-associated phenotypes. These findings position MAGEB16 as a candidate epigenetic-susceptibility factor linking germline-restricted regulatory changes, that could influence early brain development and increase the risk for neurodevelopmental conditions. See also the graphical abstract(Fig. 1).</p>","PeriodicalId":12247,"journal":{"name":"EXCLI Journal","volume":"25 ","pages":"377-386"},"PeriodicalIF":4.9,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13077175/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147689105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum: Exosomes derived from human mesenchymal stem cells preserve mouse islet survival and insulin secretion function. 勘误:源自人间充质干细胞的外泌体保护小鼠胰岛存活和胰岛素分泌功能。
IF 4.9 3区 生物学
EXCLI Journal Pub Date : 2026-03-05 eCollection Date: 2026-01-01 DOI: 10.17179/excli2026-9390
Somayeh Keshtkar, Maryam Kaviani, Fatemeh Sabet Sarvestani, Mohammad Hossein Ghahremani, Mahdokht Hossein Aghdaei, Ismail H Al-Abdullah, Negar Azarpira
{"title":"Erratum: Exosomes derived from human mesenchymal stem cells preserve mouse islet survival and insulin secretion function.","authors":"Somayeh Keshtkar, Maryam Kaviani, Fatemeh Sabet Sarvestani, Mohammad Hossein Ghahremani, Mahdokht Hossein Aghdaei, Ismail H Al-Abdullah, Negar Azarpira","doi":"10.17179/excli2026-9390","DOIUrl":"https://doi.org/10.17179/excli2026-9390","url":null,"abstract":"<p><p>[This corrects the article on p. 1064 in vol. 19, PMID: 33013264.].</p>","PeriodicalId":12247,"journal":{"name":"EXCLI Journal","volume":"25 ","pages":"375-376"},"PeriodicalIF":4.9,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13077176/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147689075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书